癫痫患者的抑郁筛查工具：对已验证工具的系统评价_Journal of Epilepsy

Authors：

 Stephanie J.Gill , SaraLukmanji , Kirsten M.Fiest , 张乐　译 , 熊维希　慕洁　审

Corresponding author：

Stephanie J.Gill, Email: nathalie.jette@albertahealthservices.ca

Keywords：

严重抑郁; 心理健康; 共病; 诊断准确性; 测量

DOI：

10.7507/2096-0247.20180071

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

抑郁影响约 25% 的癫痫患者。然而，癫痫中筛查抑郁的最佳工具尚未明确。研究的目的是系统筛查关于抑郁筛查工具在癫痫中有效性的文献。搜索MEDLINE、EMBASE 和 PsycINFO 数据库时间截至 2016 年 4 月 4 日，对国家或出版语言没有限制。摘要、全文筛查和数据提取由两名研究者进行。纳入了在癫痫中评估抑郁筛查工具有效性，并报道了诊断准确性（例如，敏感性、特异性以及阴性和阳性预测值）的研究。使用诊断准确性研究的质量评估第 2 版评估研究质量。适当时，计算诊断准确性的估计中位数和范围。共筛选 16 070 篇摘要，其中 38 篇符合纳入标准。 16 种筛选工具在 13 种语言的文章中验证了。最常用的筛查工具是神经系统疾病伴抑郁量表-供癫痫患者使用（Neurological disorders depression inventory for epilepsy，NDDI-E）（n=26）。简明国际神经精神访谈（Mini international neuropsychiatric interview，MINI）（n=19）是最常用的参考标准。在最常见的截点>15（n=12）中，NDDI-E 的中位灵敏度为 80.5%（范围 64.0～100.0），特异性为 86.2%（范围 81.0～95.6）。由于评估截点的多变性、参考标准的使用以及缺乏置信区间（CI）报告，Meta 分析不可行。许多研究证实了抑郁筛查工具，然而，关于诊断准确性的评估报道不一。在实践中，量表的有效性可能被高估了，因为截点常常是基于研究样本事后选择的。虽然，最佳工具的选择可能因使用环境和可用资源而异，但执行良好的 NDDI-E 是最常用的有效的筛查工具，它向公众免费开放，并经多种语言验证，且易于管理。

Citation： Stephanie J.Gill, SaraLukmanji, Kirsten M.Fiest, 张乐　译, 熊维希　慕洁　审. 癫痫患者的抑郁筛查工具：对已验证工具的系统评价. Journal of Epilepsy, 2018, 4(5): 426-435. doi: 10.7507/2096-0247.20180071 Copy

1.	Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 2012, 380(9859): 2163-2196.
2.	Tellez-Zenteno JF, Patten SB, Jette N, et al. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia, 2007, 48(12): 2336-2344.
3.	Fiest KM, Dykeman J, Patten SB, et al. Depression in epilepsy: a systematic review and meta-analysis. Neurology, 2013, 80(6): 590-599.
4.	DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med, 2000, 160(14): 2101-2107.
5.	Kobau R, Gilliam F, Thurman DJ. Prevalence of self-reported epilepsy or seizure disorder and its associations with self-reported depression and anxiety: results from the 2004 Health Styles Survey. Epilepsia, 2006, 47(11): 1915-1921.
6.	Hesdorffer DC, Ishihara L, Webb DJ, et al. Occurrence and recurrence of attempted suicide among people with epilepsy. JAMA Psychiatry, 2016, 73(1): 80-86.
7.	Boylan LS, Flint LA, Labovitz DL, et al. Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy. Neurology, 2004, 62(2): 258-261.
8.	Fiest KM, Patten SB, Jette N. Screening for depression and anxiety in epilepsy. Neurol Clin, 2016, 34(2): 351-361.
9.	Pettersson A, Bostrom KB, Gustavsson P, et al. Which instruments to support diagnosis of depression have sufficient accuracy? A systematic review. Nord J Psychiatry, 2015, 69(7): 497-508.
10.	Lakkis NA, Mahmassani DM. Screening instruments for depression in primary care: a concise review for clinicians. Postgrad Med, 2015, 127(1): 99-106.
11.	Gilliam FG, Barry JJ, Hermann BP, et al. Rapid detection of major depression in epilepsy: a multicentre study. Lancet Neurol, 2006, 5(5): 399-405.
12.	Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ, 2009, 339: b2535.
13.	Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med, 2011, 155(8): 529-536.
14.	Al-Asmi A, Dorvlo AS, Burke DT, et al. The detection of mood and anxiety in people with epilepsy using two-phase designs: experiences from a tertiary care centre in oman. Epilepsy Res, 2012, 98(2-3): 174-181.
15.	Alkhamees HA, Selai CE, Shorvon SD, et al. The use of the NDDI-E in arabic to identify symptoms of depression of moderate or greater severity in people with epilepsy. Epilepsy Behav, 2014, 32: 55-58.
16.	Botega NJ, Ponde MP, Medeiros P, et al. Validation of the hospital anxiety and depression scale in ambulatory epileptic patients. J Bras Psiquiatr, 1998, 47: 285-289.
17.	Brandt C, Labudda K, Illies D, et al. Rapid detection of a depressive disorder in persons with epilepsy. Validation of a german version of the NDDI-E. Nervenarzt, 2014, 85(9): 1151-1155.
18.	de Lemos Zingano B, Guarnieri R, Diaz AP, et al. Validation of diagnostic tests for depressive disorder in drug-resistant mesial temporal lobe epilepsy. Epilepsy Behav, 2015, 50: 61-66.
19.	de Oliveira GN, Kummer A, Salgado JV, et al. Brazilian version of the neurological disorders depression inventory for epilepsy (NDDI-E). Epilepsy Behav, 2010, 19(3): 328-331.
20.	de Oliveira GN, Lessa JM, Goncalves AP, et al. Screening for depression in people with epilepsy: comparative study among neurological disorders depression inventory for epilepsy (NDDI-E), hospital anxiety and depression scale depression subscale (HADS-D), and beck depression inventory (BDI). Epilepsy Behav, 2014, 34: 50-54.
21.	de Oliveira GNM, de Araujo Filho GM, Kummer A, et al. Beck depression inventory (BDI) and hamilton rating scale for depression (HAM-D) in patients with epilepsy. J Bras Psiquiatr, 2011, 60: 131-134.
22.	De Oliveira GNM, De Araujo Filho GM, Kummer A, et al. Neurological disorders depression inventory for epilepsy (NDDI-E): Brazilian version of a screening instrument [Portuguese]. JECN, 2011, 17: 49-53.
23.	Di Capua D, Garcia-Garcia ME, Reig-Ferrer A, et al. Validation of the spanish version of the neurological disorders depression inventory for epilepsy (NDDI-E). Epilepsy Behav, 2012, 24(4): 493-496.
24.	Drinovac M, Wagner H, Agrawal N, et al. Screening for depression in epilepsy: a model of an enhanced screening tool. Epilepsy Behav, 2015, 44: 67-72.
25.	Fiest KM, Patten SB, Wiebe S, et al. Validating screening tools for depression in epilepsy. Epilepsia, 2014, 55(10): 1642-1650.
26.	Friedman DE, Kung DH, Laowattana S, et al. Identifying depression in epilepsy in a busy clinical setting is enhanced with systematic screening. Seizure, 2009, 18(6): 429-433.
27.	Gandy M, Sharpe L, Perry KN, et al. Assessing the efficacy of 2 screening measures for depression in people with epilepsy. Neurology, 2012, 79(4): 371-375.
28.	Gross DW, Davies M, Jirsch JD, et al. Screening for depression in a tertiary epilepsy clinic. Can J Neurol Sci, 2014, 41(4): 525-527.
29.	Guo Y, Chen ZM, Zhang YX, et al. Reliability and validity of the chinese version of the neurological disorders depression inventory for epilepsy (C-NDDI-E). Epilepsy Behav, 2015, 45: 225-228.
30.	Hansen CP, Amiri M. Combined detection of depression and anxiety in epilepsy patients using the neurological disorders depression inventory for epilepsy and the world health organization well-being index. Seizure, 2015, 33: 41-45.
31.	Hesdorffer DC, Baldin E, Caplan R, et al. How do we measure psychiatric diagnoses? Implications of the choice of instruments in epilepsy. Epilepsy Behav, 2014, 31: 351-355.
32.	Jones JE, Hermann BP, Woodard JL, et al. Screening for major depression in epilepsy with common self-report depression inventories. Epilepsia, 2005, 46(5): 731-735.
33.	Karzmark P, Zeifert P, Barry J. Measurement of depression in epilepsy. Epilepsy Behav, 2001, 2(2): 124-128.
34.	Ko PW, Hwang J, Lim HW, et al. Reliability and validity of the Korean version of the neurological disorders depression inventory for epilepsy (K-NDDI-E). Epilepsy Behav, 2012, 25(4): 539-542.
35.	Margrove K, Mensah S, Thapar A, et al. Depression screening for patients with epilepsy in a primary care setting using the patient health questionnaire-2 and the neurological disorders depression inventory for epilepsy. Epilepsy Behav, 2011, 21(4): 387-390.
36.	Mbewe EK, Uys LR, Nkwanyana NM, et al. A primary healthcare screening tool to identify depression and anxiety disorders among people with epilepsy in zambia. Epilepsy Behav, 2013, 27(2): 296-300.
37.	Metternich B, Wagner K, Buschmann F, et al. Validation of a german version of the neurological disorders depression inventory for epilepsy (NDDI-E). Epilepsy Behav, 2012, 25(4): 485-488.
38.	Micoulaud-Franchi JA, Barkate G, Trebuchon-Da Fonseca A, et al. One step closer to a global tool for rapid screening of major depression in epilepsy: validation of the french NDDI-E. Epilepsy Behav, 2015, 44: 11-16.
39.	Mitchell AJ, Ioannou N, Rampling JM, et al. Which symptoms are indicative of depression in epilepsy settings? An analysis of the diagnostic significance of somatic and non-somatic symptoms. J Affect Disord, 2013, 150(3): 861-867.
40.	Mula M, Iudice A, La Neve A, et al. Validation of the italian version of the neurological disorders depression inventory for epilepsy (NDDI-E). Epilepsy Behav, 2012, 24(3): 329-331.
41.	Mula M, Iudice A, La Neve A, et al. Validation of the hamilton rating scale for depression in adults with epilepsy. Epilepsy Behav, 2014, 41: 122-125.
42.	Rampling J, Mitchell AJ, Von Oertzen T, et al. Screening for depression in epilepsy clinics. A comparison of conventional and visual-analog methods. Epilepsia, 2012, 53(10): 1713-1721.
43.	Rathore JS, Jehi LE, Fan Y, et al. Validation of the patient healthquestionnaire-9 (PHQ-9) for depression screening in adults with epilepsy. Epilepsy Behav, 2014, 37: 215-220.
44.	Ristic AJ, Pjevalica J, Trajkovic G, et al. Validation of the neurological disorders depression inventory for epilepsy (NDDI-E) serbian version. Epilepsy Behav, 2016, 57(Part A): 1-4.
45.	Tadokoro Y, Oshima T, Fukuchi T, et al. Screening for major depressive episodes in japanese patients with epilepsy: validation and translation of the Japanese version of neurological disorders depression inventory for epilepsy (NDDI-E). Epilepsy Behav, 2012, 25(1): 18-22.
46.	Thomson AE, Calle A, Fontela ME, et al. Screening of major depression in epilepsy: the neurologic depression disorders inventory in epilepsy-spanish version (Argentina). Epilepsia, 2014, 55(2): 331-334.
47.	Tong X, An D, Lan L, et al. Validation of the chinese version of the neurological disorders depression inventory for epilepsy (C-NDDIE) in West China. Epilepsy Behav, 2015, 47: 6-10.
48.	Wagner JL, Smith G, Ferguson PL, et al. Preliminary psychometrics of the neurological disorders depression inventory for epilepsy-youth. J Child Neurol, 2013, 28(11): 1392-1399.
49.	Walker ER, Engelhard G Jr, Thompson NJ. Using rasch measurement theory to assess three depression scales among adults with epilepsy. Seizure, 2012, 21(6): 437-443.
50.	Zis P, Yfanti P, Siatouni A, et al. Validation of the greek version of the neurological disorders depression inventory for epilepsy (NDDI-E). Epilepsy Behav, 2013, 29(3): 513-515.
51.	Egger M, Davey-Smith G, Altman D. Systematic reviews in health care: meta-analysis in context. London: John Wiley & Sons, 2008.
52.	Bjelland I, Dahl AA, Haug TT, et al. The validity of the hospital anxiety and depression scale. an updated literature review. J Psychosom Res, 2002, 52(2): 69-77.
53.	Snaith RP, Zigmond AS. The hospital anxiety and depression scale. Br Med J (Clin Res Ed), 1986, 292(6516): 344.
54.	Brislin RW. Back-translation for cross-cultural research. J Cross Cult Psychol, 1970, 1: 185-216.
55.	Jones JE, Hermann BP, Barry JJ, et al. Clinical assessment of Axis I psychiatric morbidity in chronic epilepsy: a multicenter investigation. J Neuropsychiatry Clin Neurosci, 2005, 17(2): 172-179.
56.	Sanchez-Villegas A, Schlatter J, Ortuno F, et al. Validity of a selfreported diagnosis of depression among participants in a cohort study using the structured clinical interview for DSM-IV (SCID-I). BMC Psychiatry, 2008, 8: 43.
57.	Jones JE, Austin JK, Caplan R, et al. Psychiatric disorders in children and adolescents who have epilepsy. Pediatr Rev, 2008, 29(2): e9-e14.
58.	Guilfoyle SM, Monahan S, Wesolowski C, et al. Depression screening in pediatric epilepsy: evidence for the benefit of a behavioral medicine service in early detection. Epilepsy Behav, 2015, 44: 5-10.
59.	Bossuyt PM, Reitsma JB, Bruns DE, et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. Clin Chem, 2015, 61(12): 1446-1452.
60.	Thombs BD, Benedetti A, Kloda LA, et al. Diagnostic accuracy of the edinburgh postnatal depression scale (EPDS) for detecting major depression in pregnant and postnatal women: protocol for a systematic review and individual patient data meta-analyses. BMJ Open, 2015, 5(10): e009742.
61.	Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry, 1961, 4: 561-571.
62.	Dori GA, Overholser JC. Evaluating depression severity and remission with a modified beck depression inventory. Pers Individ Dif, 2000, 28: 1045-1061.
63.	Kliem S, Mößle T, Zenger M, et al. Reliability and validity of the beck depression inventory-fast screen for medical patients in the general german population. J Affect Disord, 2014, 156: 236-239.
64.	Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand, 1983, 67(6): 361-370.
65.	Mitchell AJ, Baker-Glenn EA, Granger L, et al. Can the distress thermometer be improved by additional mood domains? Part I. Initial validation of the emotion thermometers tool. Psychooncology, 2010, 19(2): 125-133.
66.	Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med, 2001, 16(9): 606-613.
67.	Kroenke K, Spitzer RL, Williams JB. The patient health questionnaire-2: validity of a two-item depression screener. Med Care, 2003, 41(11): 1284-1292.
68.	Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry, 1960, 23: 56-62.
69.	Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas, 1977, 1: 385-401.
70.	Achenbach T. Child Behavior Checklist. In Kreutzer JS, DeLuca J, Caplan B (Eds) Encyclopedia of clinical neuropsychology. New York: Springer, 2011: 546-552.
71.	Bech P. Clinical psychometrics. Oxford: John Wiley & Sons, 2012.
72.	Butcher JN. Minnesota Multiphasic Personality Inventory-2: Manual for administration, scoring, and interpretation. Minneapolis, MN: University of Minnesota Press, 2001.

1. Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 2012, 380(9859): 2163-2196.
2. Tellez-Zenteno JF, Patten SB, Jette N, et al. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia, 2007, 48(12): 2336-2344.
3. Fiest KM, Dykeman J, Patten SB, et al. Depression in epilepsy: a systematic review and meta-analysis. Neurology, 2013, 80(6): 590-599.
4. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med, 2000, 160(14): 2101-2107.
5. Kobau R, Gilliam F, Thurman DJ. Prevalence of self-reported epilepsy or seizure disorder and its associations with self-reported depression and anxiety: results from the 2004 Health Styles Survey. Epilepsia, 2006, 47(11): 1915-1921.
6. Hesdorffer DC, Ishihara L, Webb DJ, et al. Occurrence and recurrence of attempted suicide among people with epilepsy. JAMA Psychiatry, 2016, 73(1): 80-86.
7. Boylan LS, Flint LA, Labovitz DL, et al. Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy. Neurology, 2004, 62(2): 258-261.
8. Fiest KM, Patten SB, Jette N. Screening for depression and anxiety in epilepsy. Neurol Clin, 2016, 34(2): 351-361.
9. Pettersson A, Bostrom KB, Gustavsson P, et al. Which instruments to support diagnosis of depression have sufficient accuracy? A systematic review. Nord J Psychiatry, 2015, 69(7): 497-508.
10. Lakkis NA, Mahmassani DM. Screening instruments for depression in primary care: a concise review for clinicians. Postgrad Med, 2015, 127(1): 99-106.
11. Gilliam FG, Barry JJ, Hermann BP, et al. Rapid detection of major depression in epilepsy: a multicentre study. Lancet Neurol, 2006, 5(5): 399-405.
12. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ, 2009, 339: b2535.
13. Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med, 2011, 155(8): 529-536.
14. Al-Asmi A, Dorvlo AS, Burke DT, et al. The detection of mood and anxiety in people with epilepsy using two-phase designs: experiences from a tertiary care centre in oman. Epilepsy Res, 2012, 98(2-3): 174-181.
15. Alkhamees HA, Selai CE, Shorvon SD, et al. The use of the NDDI-E in arabic to identify symptoms of depression of moderate or greater severity in people with epilepsy. Epilepsy Behav, 2014, 32: 55-58.
16. Botega NJ, Ponde MP, Medeiros P, et al. Validation of the hospital anxiety and depression scale in ambulatory epileptic patients. J Bras Psiquiatr, 1998, 47: 285-289.
17. Brandt C, Labudda K, Illies D, et al. Rapid detection of a depressive disorder in persons with epilepsy. Validation of a german version of the NDDI-E. Nervenarzt, 2014, 85(9): 1151-1155.
18. de Lemos Zingano B, Guarnieri R, Diaz AP, et al. Validation of diagnostic tests for depressive disorder in drug-resistant mesial temporal lobe epilepsy. Epilepsy Behav, 2015, 50: 61-66.
19. de Oliveira GN, Kummer A, Salgado JV, et al. Brazilian version of the neurological disorders depression inventory for epilepsy (NDDI-E). Epilepsy Behav, 2010, 19(3): 328-331.
20. de Oliveira GN, Lessa JM, Goncalves AP, et al. Screening for depression in people with epilepsy: comparative study among neurological disorders depression inventory for epilepsy (NDDI-E), hospital anxiety and depression scale depression subscale (HADS-D), and beck depression inventory (BDI). Epilepsy Behav, 2014, 34: 50-54.
21. de Oliveira GNM, de Araujo Filho GM, Kummer A, et al. Beck depression inventory (BDI) and hamilton rating scale for depression (HAM-D) in patients with epilepsy. J Bras Psiquiatr, 2011, 60: 131-134.
22. De Oliveira GNM, De Araujo Filho GM, Kummer A, et al. Neurological disorders depression inventory for epilepsy (NDDI-E): Brazilian version of a screening instrument [Portuguese]. JECN, 2011, 17: 49-53.
23. Di Capua D, Garcia-Garcia ME, Reig-Ferrer A, et al. Validation of the spanish version of the neurological disorders depression inventory for epilepsy (NDDI-E). Epilepsy Behav, 2012, 24(4): 493-496.
24. Drinovac M, Wagner H, Agrawal N, et al. Screening for depression in epilepsy: a model of an enhanced screening tool. Epilepsy Behav, 2015, 44: 67-72.
25. Fiest KM, Patten SB, Wiebe S, et al. Validating screening tools for depression in epilepsy. Epilepsia, 2014, 55(10): 1642-1650.
26. Friedman DE, Kung DH, Laowattana S, et al. Identifying depression in epilepsy in a busy clinical setting is enhanced with systematic screening. Seizure, 2009, 18(6): 429-433.
27. Gandy M, Sharpe L, Perry KN, et al. Assessing the efficacy of 2 screening measures for depression in people with epilepsy. Neurology, 2012, 79(4): 371-375.
28. Gross DW, Davies M, Jirsch JD, et al. Screening for depression in a tertiary epilepsy clinic. Can J Neurol Sci, 2014, 41(4): 525-527.
29. Guo Y, Chen ZM, Zhang YX, et al. Reliability and validity of the chinese version of the neurological disorders depression inventory for epilepsy (C-NDDI-E). Epilepsy Behav, 2015, 45: 225-228.
30. Hansen CP, Amiri M. Combined detection of depression and anxiety in epilepsy patients using the neurological disorders depression inventory for epilepsy and the world health organization well-being index. Seizure, 2015, 33: 41-45.
31. Hesdorffer DC, Baldin E, Caplan R, et al. How do we measure psychiatric diagnoses? Implications of the choice of instruments in epilepsy. Epilepsy Behav, 2014, 31: 351-355.
32. Jones JE, Hermann BP, Woodard JL, et al. Screening for major depression in epilepsy with common self-report depression inventories. Epilepsia, 2005, 46(5): 731-735.
33. Karzmark P, Zeifert P, Barry J. Measurement of depression in epilepsy. Epilepsy Behav, 2001, 2(2): 124-128.
34. Ko PW, Hwang J, Lim HW, et al. Reliability and validity of the Korean version of the neurological disorders depression inventory for epilepsy (K-NDDI-E). Epilepsy Behav, 2012, 25(4): 539-542.
35. Margrove K, Mensah S, Thapar A, et al. Depression screening for patients with epilepsy in a primary care setting using the patient health questionnaire-2 and the neurological disorders depression inventory for epilepsy. Epilepsy Behav, 2011, 21(4): 387-390.
36. Mbewe EK, Uys LR, Nkwanyana NM, et al. A primary healthcare screening tool to identify depression and anxiety disorders among people with epilepsy in zambia. Epilepsy Behav, 2013, 27(2): 296-300.
37. Metternich B, Wagner K, Buschmann F, et al. Validation of a german version of the neurological disorders depression inventory for epilepsy (NDDI-E). Epilepsy Behav, 2012, 25(4): 485-488.
38. Micoulaud-Franchi JA, Barkate G, Trebuchon-Da Fonseca A, et al. One step closer to a global tool for rapid screening of major depression in epilepsy: validation of the french NDDI-E. Epilepsy Behav, 2015, 44: 11-16.
39. Mitchell AJ, Ioannou N, Rampling JM, et al. Which symptoms are indicative of depression in epilepsy settings? An analysis of the diagnostic significance of somatic and non-somatic symptoms. J Affect Disord, 2013, 150(3): 861-867.
40. Mula M, Iudice A, La Neve A, et al. Validation of the italian version of the neurological disorders depression inventory for epilepsy (NDDI-E). Epilepsy Behav, 2012, 24(3): 329-331.
41. Mula M, Iudice A, La Neve A, et al. Validation of the hamilton rating scale for depression in adults with epilepsy. Epilepsy Behav, 2014, 41: 122-125.
42. Rampling J, Mitchell AJ, Von Oertzen T, et al. Screening for depression in epilepsy clinics. A comparison of conventional and visual-analog methods. Epilepsia, 2012, 53(10): 1713-1721.
43. Rathore JS, Jehi LE, Fan Y, et al. Validation of the patient healthquestionnaire-9 (PHQ-9) for depression screening in adults with epilepsy. Epilepsy Behav, 2014, 37: 215-220.
44. Ristic AJ, Pjevalica J, Trajkovic G, et al. Validation of the neurological disorders depression inventory for epilepsy (NDDI-E) serbian version. Epilepsy Behav, 2016, 57(Part A): 1-4.
45. Tadokoro Y, Oshima T, Fukuchi T, et al. Screening for major depressive episodes in japanese patients with epilepsy: validation and translation of the Japanese version of neurological disorders depression inventory for epilepsy (NDDI-E). Epilepsy Behav, 2012, 25(1): 18-22.
46. Thomson AE, Calle A, Fontela ME, et al. Screening of major depression in epilepsy: the neurologic depression disorders inventory in epilepsy-spanish version (Argentina). Epilepsia, 2014, 55(2): 331-334.
47. Tong X, An D, Lan L, et al. Validation of the chinese version of the neurological disorders depression inventory for epilepsy (C-NDDIE) in West China. Epilepsy Behav, 2015, 47: 6-10.
48. Wagner JL, Smith G, Ferguson PL, et al. Preliminary psychometrics of the neurological disorders depression inventory for epilepsy-youth. J Child Neurol, 2013, 28(11): 1392-1399.
49. Walker ER, Engelhard G Jr, Thompson NJ. Using rasch measurement theory to assess three depression scales among adults with epilepsy. Seizure, 2012, 21(6): 437-443.
50. Zis P, Yfanti P, Siatouni A, et al. Validation of the greek version of the neurological disorders depression inventory for epilepsy (NDDI-E). Epilepsy Behav, 2013, 29(3): 513-515.
51. Egger M, Davey-Smith G, Altman D. Systematic reviews in health care: meta-analysis in context. London: John Wiley & Sons, 2008.
52. Bjelland I, Dahl AA, Haug TT, et al. The validity of the hospital anxiety and depression scale. an updated literature review. J Psychosom Res, 2002, 52(2): 69-77.
53. Snaith RP, Zigmond AS. The hospital anxiety and depression scale. Br Med J (Clin Res Ed), 1986, 292(6516): 344.
54. Brislin RW. Back-translation for cross-cultural research. J Cross Cult Psychol, 1970, 1: 185-216.
55. Jones JE, Hermann BP, Barry JJ, et al. Clinical assessment of Axis I psychiatric morbidity in chronic epilepsy: a multicenter investigation. J Neuropsychiatry Clin Neurosci, 2005, 17(2): 172-179.
56. Sanchez-Villegas A, Schlatter J, Ortuno F, et al. Validity of a selfreported diagnosis of depression among participants in a cohort study using the structured clinical interview for DSM-IV (SCID-I). BMC Psychiatry, 2008, 8: 43.
57. Jones JE, Austin JK, Caplan R, et al. Psychiatric disorders in children and adolescents who have epilepsy. Pediatr Rev, 2008, 29(2): e9-e14.
58. Guilfoyle SM, Monahan S, Wesolowski C, et al. Depression screening in pediatric epilepsy: evidence for the benefit of a behavioral medicine service in early detection. Epilepsy Behav, 2015, 44: 5-10.
59. Bossuyt PM, Reitsma JB, Bruns DE, et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. Clin Chem, 2015, 61(12): 1446-1452.
60. Thombs BD, Benedetti A, Kloda LA, et al. Diagnostic accuracy of the edinburgh postnatal depression scale (EPDS) for detecting major depression in pregnant and postnatal women: protocol for a systematic review and individual patient data meta-analyses. BMJ Open, 2015, 5(10): e009742.
61. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry, 1961, 4: 561-571.
62. Dori GA, Overholser JC. Evaluating depression severity and remission with a modified beck depression inventory. Pers Individ Dif, 2000, 28: 1045-1061.
63. Kliem S, Mößle T, Zenger M, et al. Reliability and validity of the beck depression inventory-fast screen for medical patients in the general german population. J Affect Disord, 2014, 156: 236-239.
64. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand, 1983, 67(6): 361-370.
65. Mitchell AJ, Baker-Glenn EA, Granger L, et al. Can the distress thermometer be improved by additional mood domains? Part I. Initial validation of the emotion thermometers tool. Psychooncology, 2010, 19(2): 125-133.
66. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med, 2001, 16(9): 606-613.
67. Kroenke K, Spitzer RL, Williams JB. The patient health questionnaire-2: validity of a two-item depression screener. Med Care, 2003, 41(11): 1284-1292.
68. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry, 1960, 23: 56-62.
69. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas, 1977, 1: 385-401.
70. Achenbach T. Child Behavior Checklist. In Kreutzer JS, DeLuca J, Caplan B (Eds) Encyclopedia of clinical neuropsychology. New York: Springer, 2011: 546-552.
71. Bech P. Clinical psychometrics. Oxford: John Wiley & Sons, 2012.
72. Butcher JN. Minnesota Multiphasic Personality Inventory-2: Manual for administration, scoring, and interpretation. Minneapolis, MN: University of Minnesota Press, 2001.

Previous Article
突触融合蛋白结合蛋白 1 基因与癫痫性脑病的研究进展
Next Article
立体脑电图颅内电极植入的准确性：系统评价和 Meta 分析

Journal of Epilepsy

癫痫患者的抑郁筛查工具：对已验证工具的系统评价

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content